Envoy Medical (NASDAQ: COCH) has announced the issuance of multiple patents across Australia and Europe, as well as the upcoming grant of an additional European patent, further expanding the company’s intellectual property (IP) portfolio.
According to Envoy, the newly granted and pending patents cover technologies related to fully implanted cochlear implant platforms, removable earplug sensors, implanted battery systems, integrated signal analysis functionality, and rechargeable implant battery management.
In a statement, Brent Lucas, CEO, Envoy, commented, “As we continue advancing fully implanted hearing technology, protecting the innovation behind these systems remains a key priority for Envoy Medical. These patents further strengthen our intellectual property portfolio across critical areas including implant architecture, signal processing, and rechargeable battery systems, while reinforcing our long-term position in the cochlear implant market.”
